MyFinsight
Home
Blog
About
Back
Income Statement
Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)
source: myfinsight.com
Net loss
-$223K
(30.75%↑ Y/Y)
Operating loss
-$199K
(36.83%↑ Y/Y)
Total financial
expense
-$24K
(-242.86%↓ Y/Y)
General and
administrative expenses
$159K
(-8.62%↓ Y/Y)
Research and development
expenses
$40K
(-71.63%↓ Y/Y)
Back